The Cigna Group Policyholder Benefits and Claims Incurred, Ceded
The Cigna Group (CI) reported Policyholder Benefits and Claims Incurred, Ceded of $671.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded · last filed 2026-02-26
- The Cigna Group policyholder benefits and claims incurred, ceded for the quarter ending 2021-12-31 was $133.00M, a 291.18% increase year-over-year.
- The Cigna Group policyholder benefits and claims incurred, ceded for the quarter ending 2021-09-30 was $138.00M, a 17.95% increase year-over-year.
- The Cigna Group policyholder benefits and claims incurred, ceded for the quarter ending 2021-06-30 was $133.00M, a 30.39% increase year-over-year.
- The Cigna Group policyholder benefits and claims incurred, ceded for the quarter ending 2021-03-31 was $148.00M, a 16.85% decline year-over-year.
- The Cigna Group policyholder benefits and claims incurred, ceded for fiscal 2025 was $671.00M, a 17.10% increase from fiscal 2024.
- The Cigna Group policyholder benefits and claims incurred, ceded for fiscal 2024 was $573.00M, a 25.66% increase from fiscal 2023.
- The Cigna Group policyholder benefits and claims incurred, ceded for fiscal 2023 was $456.00M, a 35.04% decline from fiscal 2022.
- The Cigna Group policyholder benefits and claims incurred, ceded for fiscal 2022 was $702.00M, a 27.17% increase from fiscal 2021.
| Period end | Policyholder Benefits and Claims Incurred, Ceded 3 month | Policyholder Benefits and Claims Incurred, Ceded 6 month | Policyholder Benefits and Claims Incurred, Ceded 9 month | Policyholder Benefits and Claims Incurred, Ceded 12 month |
|---|---|---|---|---|
| 2025-12-31 | $671.00M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $573.00M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $456.00M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $702.00M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $271.00M derived: sum of 2 quarters · filed 2024-02-29 | $404.00M derived: sum of 3 quarters · filed 2024-02-29 | $552.00M 10-K · filed 2024-02-29 |
| 2021-09-30 | $138.00M 10-Q · filed 2021-11-04 | $271.00M derived: sum of 2 quarters · filed 2021-11-04 | $419.00M 10-Q · filed 2021-11-04 | $453.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $133.00M 10-Q · filed 2021-08-05 | $281.00M 10-Q · filed 2021-08-05 | $315.00M derived: sum of 3 quarters · filed 2023-02-23 | $432.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $148.00M 10-Q · filed 2021-05-07 | $182.00M derived: sum of 2 quarters · filed 2023-02-23 | $299.00M derived: sum of 3 quarters · filed 2023-02-23 | $401.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $151.00M derived: sum of 2 quarters · filed 2023-02-23 | $253.00M derived: sum of 3 quarters · filed 2023-02-23 | $431.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $117.00M 10-Q · filed 2021-11-04 | $219.00M derived: sum of 2 quarters · filed 2021-11-04 | $397.00M 10-Q · filed 2021-11-04 | $500.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $102.00M 10-Q · filed 2021-08-05 | $280.00M 10-Q · filed 2021-08-05 | $383.00M derived: sum of 3 quarters · filed 2022-02-24 | $563.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $178.00M 10-Q · filed 2021-05-07 | $281.00M derived: sum of 2 quarters · filed 2022-02-24 | $461.00M derived: sum of 3 quarters · filed 2022-02-24 | $514.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $283.00M derived: sum of 2 quarters · filed 2022-02-24 | $336.00M derived: sum of 3 quarters · filed 2022-02-24 | $395.00M 10-K · filed 2022-02-24 |
| 2019-09-30 | $180.00M 10-Q · filed 2020-11-05 | $233.00M derived: sum of 2 quarters · filed 2020-11-05 | $292.00M 10-Q · filed 2020-11-05 | $444.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $53.00M 10-Q · filed 2020-08-06 | $112.00M 10-Q · filed 2020-08-06 | $264.00M derived: sum of 3 quarters · filed 2021-02-25 | $404.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $59.00M 10-Q · filed 2020-05-07 | $211.00M derived: sum of 2 quarters · filed 2021-02-25 | $351.00M derived: sum of 3 quarters · filed 2021-02-25 | $407.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $152.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $292.00M derived: sum of 2 quarters · filed 2021-02-25 | $348.00M derived: sum of 3 quarters · filed 2021-02-25 | $452.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $140.00M 10-Q · filed 2019-10-31 | $196.00M derived: sum of 2 quarters · filed 2019-10-31 | $300.00M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $56.00M 10-Q · filed 2019-08-01 | $160.00M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $104.00M 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $325.00M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $540.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |